GENEVA, July 31 -- PARR BIOTECHNOLOGY (HEBEI) CO., LTD. filed a patent application (CN2025/147418) for “PHARMACEUTICAL COMPOSITION COMPRISING TLR AGONIST COMBINATION, COMBINATION FORMULATION, PHARMACEUTICAL USE, AND THERAPEUTIC METHOD”. With publication no. WO/2026/157844, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 39/395
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....